Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Microbiota, a diplomatic immunity?
  3. Expert interview: Pr. Brigitte Dréno
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Microbiota, a diplomatic immunity?
  3. Expert interview: Pr. Brigitte Dréno
Dermatology

Expert interview: Pr. Brigitte Dréno

Immunity

Atopic dermatitis (AD) is a chronic inflammatory skin disease that appears in periodic flareups. Like asthma, hay fever or allergic conjunctivitis, it is classified as an allergic disease. The disease causes very poorly defined oozing red lesions to appear in specific locations on the skin, such as in the folds of the elbow or behind the knees, but at times also on the face or the rest of the body. AD usually appears in early childhood, and may persist into adulthood. The causes are multifactorial and complex and include a genetic predisposition (mutation of the skin protein, filaggrin), an alteration of the skin barrier, a dysbiosis of the skin and gut microbiota, and immune dysregulation.

AD affects 15%-20% of children and 10% of adults in “developed” countries. The number of cases has increased significantly in recent decades due to pollution and contact with allergens.1

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

About this article

Author

Pr. Brigitte Dréno

Professor

Professor of Dermatology exceptional grade, Chairman of the department of Dermato-Oncology, Chairman of the Federation of Oncology and Director of the GMP Unit of Cell and Gene Therapy in University Hospital Nantes, France. She is also Vice Dean of the Faculty of Medicine of Nantes, France, President of National University Council of Dermatology.

Her research interest focuses on cutaneous cancers, translational research, drug development and immunotherapy, cutaneous Adverse Events and anti- Cancer drugs and cutaneous microbiome and chronic inflammatory disease.

See the author
Created 24 November 2021
Updated 25 November 2021

What factors cause flare-ups ? 


Inflammatory outbreaks can be triggered by multiple factors, including stress, pollution, cold, humidity, certain allergens (pollen), certain medications, woolen clothing, and certain cosmetics containing plants or essential oils.

The causes of atopic dermatitis are multifactorial and complex and include a genetic predisposition, an alteration of the skin barrier, a dysbiosis of the skin and gut microbiota, and immune dysregulation.

Pr. Brigitte Dréno

What do we know about the links between atopic dermatitis, the microbiota and immunity?

On a pathophysiological level, AD is characterized by an alteration of the skin barrier, a skin and gut dysbiosis, and immune dysregulation with the activation of Th2 lymphocytes. This immune dysregulation leads to a major cytokine surge, which in turn causes the inflammatory reactions.2

An alteration of the skin barrier is the starting point for a dysbiosis of the skin microbiota characterized by a reduction in bacterial diversity and the proliferation of Staphylococcus aureus. Allergen penetration leads to the activation of keratinocytes and the production of interleukin (IL-33, IL-25, TSLP), resulting in the differentiation of Th2 lymphocytes. These in turn secrete pro-inflammatory cytokines (IL-4, IL-5 and IL-13) characteristic of Type 2 inflammation (Fig 9). These cytokines directly activate the sensory nerves, provoking pruritus.

With chronic lesions, the skin barrier repairs itself poorly and becomes thicker, since it is subject to chronic inflammation. There is also a progressive increase in cytokines and Th cells (Th1, Th2, Th22) which secrete cytokines that contribute to the destruction of keratinocytes. Lastly, a gut dysbiosis may play a role in the disease’s pathophysiological mechanism.3

FIGURE 9: Pathogenesis, main mechanisms and pathophysiology of atopic dermatitis.


Adapted from Sugita K et al, 20204
infographic

What have recent discoveries about the microbiota taught you? Has your practice changed?

Recent discoveries about the microbiota have led me to better understand the importance of maintaining and repairing the skin barrier to control inflammation. As a systemic treatment, I advise my patients to use a cleansing gel that preserves the skin’s pH (pH ~5, avoid products with a basic pH), as well as a moisturizer and tailored cosmetic products. The findings also help us to better understand the skin’s immunological system and how to respect the skin’s microbiota.

The immune dysregulation in atopic dermatits leads to a major cytokine surge, which in turn causes the inflammatory reactions.2

Pr. Brigitte Dréno

What are your thoughts on the use of probiotics to treat AD or prevent relapse?

There are many ways to rebalance the skin microbiota in case of AD (probiotics, prebiotics, symbiotics, etc.)5 but the postbiotic approach seems to me the most interesting. Postbiotics are preparations of inanimate microorganisms and/or their components that confers a health benefit on the host.6 They can restore the skin barrier via an anti-inflammatory action that allows bacteria to recolonize, therefore having a long-term impact on the microbiota. Oral probiotics or prebiotics are another interesting approach to regulating the intestinal system, which itself plays a general immunomodulatory role in the immune system.7

Sources

1 Ständer S. Atopic Dermatitis. N Engl J Med. 2021 Mar 25;384(12):1136-1143.

2 Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020 Aug 1;396(10247):345-360.

3 Kim JE, Kim HS. Microbiome of the Skin and Gut in Atopic Dermatitis (AD): Understanding the Pathophysiology and Finding Novel Management Strategies. J Clin Med. 2019 Apr 2;8(4):444. 

4 Sugita K, Akdis CA. Recent developments and advances in atopic dermatitis and food allergy. Allergol Int. 2020 Apr;69(2):204-214. 

5 Li W, Yosipovitch G. The Role of the Microbiome and Microbiome-Derived Metabolites in Atopic Dermatitis and Non-Histaminergic Itch. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):44-50. 

6 Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021 May 4. 

Tags
Immunity Skin microbiota Gut microbiota Atopic Dermatitis Eczema Dysbiosis Staphylococcus aureus Skin Gut-skin axis Immune Immune system Immune response Flare-up

en_view en_sources

    Focus
    Microbiota, a diplomatic immunity?
    • Introduction
      • Understanding the complex interplay between the microbiota and immunity is only just beginning
    • Intestinal Immunity
      • The infant's gut at the heart of immunity
      • Factors influencing microbiota development and maturation of the immune system early in life
      • The impact of western diet on the mucus layer
      • Dampening gastrointestinal inflammation through nutrition
    • Gut microbiota influences respiratory immunity
      • The gut microbiota is involved in the lung’s defense against viral respiratory infections
      • Gut-lung axis in viral respiratory infections
      • The hygiene hypothesis and the COVID-19 pandemic
      • Targeting the gut microbiota to optimize vaccine efficacy?
    • Role of the microbiota in skin immunity and atopic dermatitis
      • Expert interview: Pr. Brigitte Dréno
    • Conclusion
      • What to take away? Intestinal Immunity
      • What to take away? Respiratory immunity
      • What to take away? Skin immunity
    Created 24 November 2021
    Updated 25 November 2021

    About this article

    To know more about this topic.

    Main topic

    Immunity

    Content type

    Dossier detail

    Author

    Pr. Brigitte Dréno

    Professor

    Professor of Dermatology exceptional grade, Chairman of the department of Dermato-Oncology, Chairman of the Federation of Oncology and Director of the GMP Unit of Cell and Gene Therapy in University Hospital Nantes, France. She is also Vice Dean of the Faculty of Medicine of Nantes, France, President of National University Council of Dermatology.

    Her research interest focuses on cutaneous cancers, translational research, drug development and immunotherapy, cutaneous Adverse Events and anti- Cancer drugs and cutaneous microbiome and chronic inflammatory disease.

    See the author
    Targeting the gut microbiota to optimize vaccine efficacy?
    What to take away? Intestinal Immunity
    Focus

    Microbiota, a diplomatic immunity?

    Introduction

    Understanding the complex interplay between the microbiota and immunity is only just beginning

    Intestinal Immunity

    The infant's gut at the heart of immunity Factors influencing microbiota development and maturation of the immune system early in life The impact of western diet on the mucus layer Dampening gastrointestinal inflammation through nutrition

    Gut microbiota influences respiratory immunity

    The gut microbiota is involved in the lung’s defense against viral respiratory infections Gut-lung axis in viral respiratory infections The hygiene hypothesis and the COVID-19 pandemic Targeting the gut microbiota to optimize vaccine efficacy?

    Role of the microbiota in skin immunity and atopic dermatitis

    Expert interview: Pr. Brigitte Dréno

    Conclusion

    What to take away? Intestinal Immunity What to take away? Respiratory immunity What to take away? Skin immunity

    Continue reading

    News
    20.03.2023

    The role of Bifidobacteria in irritable bowel syndrome (IBS)

    Read the article
    09.03.2023

    Each subtype of Irritable Bowel Syndrome (IBS) has its own dysbiosis

    Read the article

    Xpeer course: Detection, Prevention and Treatment of Gut Microbiome Dysbiosis

    Find out more
    Parkinson : le microbiote intestinal, chef d’orchestre des mécanismes pathogéniques ?
    27.02.2023

    Does the gut microbiota orchestrate pathogenic mechanisms in Parkinson’s disease?

    Read the article

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more

    Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

    Commented article - Children's section By Pr. Emmanuel M...

    Find out more

    Impact of beer and non alcoholic consumption on the gut microbiota

    By Pr. Bernd SchnablDivision of Gastroenterology, San Diego Digestive Diseases Research Center (SDDRC), UC ...

    Find out more
    Everything you need to know about Microbiota & Immunity
    15.09.2022

    Everything you need to know about Microbiota & Immunity

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    20.03.2023

    The role of Bifidobacteria in irritable bowel syndrome (IBS)

    Read the article
    14.03.2023

    Positive impact of running on gut microbiota and adolescent depression

    Read the article
    09.03.2023

    Each subtype of Irritable Bowel Syndrome (IBS) has its own dysbiosis

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo